PulseAugur
EN
LIVE 20:35:44

Former OpenAI Exec Launches AI Startup ChronicleBio to Cure Chronic Diseases

Fidji Simo, a former senior executive at OpenAI, has launched ChronicleBio, a startup focused on using AI to find cures for chronic diseases like POTS. The company has collected over 3,500 vials of blood from nearly 700 patients and extracted 153 terabytes of data, which is significantly more than the data used to train GPT 3.5. ChronicleBio has raised $15 million and plans to offer home blood draws to gather more biological data for AI-driven drug discovery and clinical trial improvements. AI

IMPACT Could accelerate AI's application in personalized medicine and drug discovery for chronic conditions.

RANK_REASON Founding of a new AI-focused biotech company by a high-profile former executive of a major AI lab. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on Fortune →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Former OpenAI Exec Launches AI Startup ChronicleBio to Cure Chronic Diseases

COVERAGE [1]

  1. Fortune TIER_1 English(EN) · Emily Forlini ·

    Exclusive: Former OpenAI exec Fidji Simo discusses her battle with POTS and her startup’s plans to cure it with AI and 3,500 vials of blood (so far)

    Simo is a cofounder of ChronicleBio, which aims to cure complex chronic diseases by analyzing biological data with the latest AI models.